Sign inJoin waitlistJoin the waitlist

JL

John Link

Physician · MemorialCare

Credentials: · · · ·

History

MemorialCare
2021–Present

Medical Oncology
1975–1977
Internal Medicine
1972–1975
Keck Sch of Med of the Univ of Southern Calif
1968–1972

Research

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology · 2017 · 456 citations
Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer
Journal of Clinical Oncology · 2009 · 236 citations
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial
Clinical Breast Cancer · 2021 · 174 citations

JW
James Waisman
5 papers
Andrew Coveler
2 papers · 2 as a fellow
Beverly Moy
2 papers
FX
Feng Xu
2 papers
FH
Frankie Holmes
2 papers
JB
Jonathan Blitzer
2 papers
LS
Lupe Salazar
2 papers
MD
Mary Disis
2 papers
ND
Neelima Denduluri
2 papers
PF
Patricia Fintak
2 papers
RN
Robert Nagourney
2 papers
Warren Paroly
2 papers · 2 as a fellow